Published in Appl Microbiol on January 01, 1971
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol (1986) 2.26
Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico. Vector Borne Zoonotic Dis (2010) 1.03
Dengue in the Seychelles. Bull World Health Organ (1981) 0.99
Lymphoreticular and myeloid pathogenesis of Venezuelan equine encephalitis in hamsters. Am J Pathol (1976) 0.93
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
Neutralizing antibody responses of humans and mice to vaccination with Venezuelan encephalitis (TC-83) virus. J Clin Microbiol (1979) 0.90
Effect of heat-labile factors on the neutralization of vaccinia virus by human. Infect Immun (1973) 0.88
Effect of adjuvant vaccines on dengue virus type 2 immune ascitic fluid production. J Clin Microbiol (1985) 0.75
A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology (1956) 6.41
The dengue group of viruses and its family relationships. Bacteriol Rev (1950) 2.68
The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses. Am J Trop Med Hyg (1966) 2.45
Kinetic studies on the neutralization reaction between Japanese encephalitis virus and antiserum. Virology (1963) 1.31
Immunological relationship between measles and distemper viruses. Proc Soc Exp Biol Med (1957) 1.24
Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum. J Immunol (1967) 0.99
Viral inhibitors in normal animal sera. Tex Rep Biol Med (1958) 0.95
Studies on arthropod-borne viruses of Tongaland. VII. Simbu virus, a hitherto unknown agent isolated from Aedes (Banksinella) circumluteolus Theo. S Afr J Med Sci (1957) 0.92
The persistence of Eastern encephalitis serologic reactivity following overt and inapparent human infection--an eight year follow-up. Am J Epidemiol (1968) 0.90
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science (1974) 3.86
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71
Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol (1984) 3.27
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet (2001) 3.09
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol (1984) 2.95
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ (1981) 2.36
Lassa fever. Trop Doct (1973) 2.32
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol (1986) 2.26
Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North Carolina. J Wildl Dis (1986) 2.04
Parasitism by Ixodes dammini (Acari: Ixodidae) and antibodies to spirochetes in mammals at Lyme disease foci in Connecticut, USA. J Med Entomol (1984) 2.02
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis (1995) 1.97
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92
Arenoviruses in Vero cells: ultrastructural studies. J Virol (1970) 1.91
Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 1.91
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86
Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology (1996) 1.84
Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures. Appl Microbiol (1969) 1.84
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79
The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ (1973) 1.79
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69
Antibodies to spirochetes in white-tailed deer and prevalence of infected ticks from foci of Lyme disease in Connecticut. J Wildl Dis (1984) 1.60
Lassa fever and Marburg virus disease. WHO Chron (1974) 1.58
Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57
Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest (1983) 1.55
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54
Experimental infection of horses with three strains of Venezuelan equine encephalomyelitis virus. I. Clinical and virological studies. Am J Epidemiol (1971) 1.52
Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg (1984) 1.50
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
Arthropod-borne encephalitides in the Americas. Bull World Health Organ (1979) 1.47
Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol (1971) 1.45
Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod (1992) 1.43
Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol (1989) 1.43
Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg (1990) 1.41
Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin. Am J Trop Med Hyg (1980) 1.38
Reevaluation of the western equine encephalitis antigenic complex of alphaviruses (family Togaviridae) as determined by neutralization tests. Am J Trop Med Hyg (1988) 1.38
Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun (1995) 1.35
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
Recent isolations of Lassa virus from Nigerian rodents. Bull World Health Organ (1975) 1.31
Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol (1986) 1.30
Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology (1997) 1.27
Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification. Ann N Y Acad Sci (1980) 1.27
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine (1997) 1.26
Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet (1985) 1.26
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun (1999) 1.25
Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg (1980) 1.24
Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23
Laboratory transmission of eastern equine encephalomyelitis virus to chickens by chicken mites (Acari: Dermanyssidae). J Med Entomol (1993) 1.23
Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg (1977) 1.22
Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J Infect Dis (1987) 1.20
Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J Gen Virol (1994) 1.20
Imported Lassa fever--reexamining the algorithms. N Engl J Med (1990) 1.18
Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. Arch Pathol (1975) 1.16
Geographic distribution of humans, raccoons, and white-footed mice with antibodies to Lyme disease spirochetes in Connecticut. Yale J Biol Med (1985) 1.16
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]. Med Trop (Mars) (1981) 1.16
Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine (1997) 1.16
A field study on the effects of Fort Morgan virus, an arbovirus transmitted by swallow bugs, on the reproductive success of cliff swallows and symbiotic house sparrows in Morgan County, Colorado, 1976. Am J Trop Med Hyg (1984) 1.15
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology (2001) 1.14
Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol (1988) 1.13
Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology (1989) 1.13
Yellow fever vector live-virus vaccines: West Nile virus vaccine development. Trends Mol Med (2001) 1.13
Morphological identification of the agent of Korean haemorrhagic fever (Hantaan virus)as a member of the Bunyaviridae. Lancet (1982) 1.13
Investigation of a possible yellow fever epidemic and serosurvey for flavivirus infections in northern Cameroon, 1984. Bull World Health Organ (1987) 1.12
Genetic and epidemiological studies of dengue type 2 viruses by hybridization using synthetic deoxyoligonucleotides as probes. J Gen Virol (1986) 1.12
Epidemic yellow fever in eastern Nigeria, 1986. Lancet (1988) 1.12
Serological and virological evidence of a Hantaan virus-related enzootic in the United States. J Infect Dis (1985) 1.12
Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res (1988) 1.11
Recovery of Tonate virus ("Bijou Bridge" strain), a member of the Venezuelan equine encephalomyelitis virus complex, from Cliff Swallow nest bugs (Oeciacus vicarius) and nestling birds in North America. Am J Trop Med Hyg (1980) 1.11
Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am J Trop Med Hyg (1981) 1.11
Studies on California encephalitis in Minnesota. Am J Epidemiol (1970) 1.10
Characterization of Fort Morgan virus, an alphavirus of the western equine encephalitis virus complex in an unusual ecosystem. Am J Trop Med Hyg (1980) 1.09
Diagnosis of Lassa fever and the isolation and management of patients. Bull World Health Organ (1975) 1.09
Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program. Am J Trop Med Hyg (1985) 1.09
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun (2000) 1.09
Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles. Arch Virol (1995) 1.09
Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08
Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J Infect Dis (1996) 1.07
Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg (2000) 1.05
Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Arch Virol (1985) 1.04
Sindbis virus isolations from Saudi Arabian mosquitoes. Trans R Soc Trop Med Hyg (1985) 1.04
Aedes albopictus in the United States: rapid spread of a potential disease vector. J Am Mosq Control Assoc (1988) 1.04
Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine (1999) 1.03
Importance of nonhuman primates in yellow fever epidemiology in Nigeria. Trop Geogr Med (1973) 1.03
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun (1997) 1.02
Comparison of immunization methods for producing reference adenovirus antisera in horses. Appl Microbiol (1972) 1.02
Potential for insect transmission of HIV: experimental exposure of Cimex hemipterus and Toxorhynchites amboinensis to human immunodeficiency virus. J Infect Dis (1989) 1.01
Arbovirus subtyping: applications to epidemiologic studies, availability of reagents, and testing services. Am J Epidemiol (1981) 1.01
Adult respiratory distress syndrome associated with miliary tuberculosis. Crit Care Med (1985) 1.01
Effect of antilymphocyte serium on tacaribe virus infection in infant mice. Infect Immun (1971) 1.01
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine (1999) 1.00